Copilot Agents Solutions Series – Connecting Veeva Vault PromoMats

This video, part of Microsoft's Copilot Agents Solutions Series, explores how organizations in the life sciences industry can extend the capabilities of Microsoft 365 Copilot by leveraging enterprise data from Veeva Vault PromoMats through AI agents and Microsoft 365 Graph Connectors. The discussion highlights the critical need for life sciences companies to accelerate content creation for marketing assets while ensuring strict regulatory compliance. It introduces the concept of custom AI agents that can be grounded on specific enterprise data sources, moving beyond generic web or M365 data. The speakers emphasize that these agents, particularly the newly available Veeva Vault PromoMats Graph Connector (now in public preview), enable a no-code approach to building powerful, industry-specific AI solutions, directly addressing pain points unique to the pharmaceutical and biotech sectors.

Key Takeaways:

• Veeva Vault Integration with Microsoft Copilot: Microsoft has partnered with Veeva to develop Graph Connectors for various Veeva modules, with the Veeva Vault PromoMats connector now in public preview, allowing life sciences companies to integrate their compliant content management system with Microsoft 365 Copilot.
• No-Code AI Agent Creation for Life Sciences: The video demonstrates how M365 administrators can enable Graph Connectors, allowing end-users to build custom AI agents with minimal setup and no coding, specifically grounded on Veeva Vault PromoMats data, to address industry-specific use cases.
• Enhanced Commercial Operations and Compliance: By connecting Copilot to Veeva Vault PromoMats, life sciences firms can leverage generative AI for faster creation of marketing assets and other content, while ensuring that the AI's responses and generated content are grounded in compliant, approved data, thus streamlining operations and maintaining regulatory adherence.
• Addressing Industry-Specific Pain Points: The solution directly targets challenges in life sciences, such as the need for rapid, compliant content creation and access to specialized data (e.g., clinical trial information, regulatory documents) that is unique to the sector.
• Future Expansion of Industry-Specific AI: This is the first in a six-part series focusing on healthcare and life sciences, indicating Microsoft's commitment to developing more industry-specific AI solutions and Graph Connectors for critical enterprise systems.